Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk J Wojno

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Urologic Clinics of North America|July 30, 2011
Molecular markers that can be utilized in diet and dietary supplement researchMark A Moyad, Kirk J Wojno
Urology|January 31, 2004
Individual submission and embedding of prostate biopsies decreases rates of equivocal pathology reportsChakshu Gupta, Jian Z Ren, Kirk J Wojno
The Journal of Urology|July 11, 2003
Late renal metastasis of endometrial adenocarcinomaChaksu Gupta, Kirk J Wojno, Edward W Schervish
Urology|December 20, 2005
Analysis of membrane-bound complement regulatory proteins in prostate cancerRobert D Loberg, Kirk J Wojno, LaShon L Day, et al.
The Prostate|September 17, 2013
The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancerConrad David Valdez, Lakshmi Kunju, Stephanie Daignault, et al.
Cancer|June 12, 2009
Rational approach to implementation of prostate cancer antigen 3 into clinical careRou Wang, Arul M Chinnaiyan, Rodney L Dunn, et al.
Cancer Research|January 7, 2006
Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancerMichael T McCabe, Jonathan A Low, Stephanie Daignault, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Perineural invasion is a marker for pathologically advanced disease in localized prostate cancerIrwin H Lee, Rebecca Roberts, Rajal B Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
5-aza-2'-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancerChristoph S Zorn, Kirk J Wojno, Michael T McCabe, et al.
Urology|February 8, 2006
Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostateMichael E Ray, Kirk J Wojno, Neal S Goldstein, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Urologic Clinics of North America|July 30, 2011
Molecular markers that can be utilized in diet and dietary supplement researchMark A Moyad, Kirk J Wojno
Urology|January 31, 2004
Individual submission and embedding of prostate biopsies decreases rates of equivocal pathology reportsChakshu Gupta, Jian Z Ren, Kirk J Wojno
The Journal of Urology|July 11, 2003
Late renal metastasis of endometrial adenocarcinomaChaksu Gupta, Kirk J Wojno, Edward W Schervish
Urology|December 20, 2005
Analysis of membrane-bound complement regulatory proteins in prostate cancerRobert D Loberg, Kirk J Wojno, LaShon L Day, et al.
The Prostate|September 17, 2013
The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancerConrad David Valdez, Lakshmi Kunju, Stephanie Daignault, et al.
Cancer|June 12, 2009
Rational approach to implementation of prostate cancer antigen 3 into clinical careRou Wang, Arul M Chinnaiyan, Rodney L Dunn, et al.
Cancer Research|January 7, 2006
Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancerMichael T McCabe, Jonathan A Low, Stephanie Daignault, et al.
International Journal of Radiation Oncology, Biology, Physics|April 3, 2007
Perineural invasion is a marker for pathologically advanced disease in localized prostate cancerIrwin H Lee, Rebecca Roberts, Rajal B Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
5-aza-2'-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancerChristoph S Zorn, Kirk J Wojno, Michael T McCabe, et al.
Urology|February 8, 2006
Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostateMichael E Ray, Kirk J Wojno, Neal S Goldstein, et al.
Pageof 3